HPC for bone marrow treatments

The ONPRHPCD will be created within 2 years and operated by the National Institute of Health (NIH – INS). Its main purpose is to facilitate the search for HPC donors and their connection with recipient patients who require them. The system must guarantee the confidentiality of donors and of the recipient information at each stage.

This registry will be articulated with the National Registry of Donors and, additionally, it will be linked with the other existing registries in the country and international ones of the same nature for the exchange of information, management of donations, transportation of biologics, authorization procedures and other necessary steps for the international donation procedures.

The registry will also include the results of the samples analyzed to determine the histocompatibility of the types of human leukocyte antigens HLA of the donors.

On the one hand, recipients of HPC, umbilical cord blood and related therapeutic products are defined as any person whose state of health requires it, with priority given to minors diagnosed with or suspected of having cancer, while donors are defined as any civilly capable person over eighteen years of age (minors may be authorized on an exceptional basis). Donors will be able to revoke their consent without any liability at their own expense, prior to the start of the extraction procedure.

Finally, the Ministry of Health and Social Protection (MoH) who will monitor compliance of the law, shall submit an annual report to The Congress of the Republic of Colombia. Regarding the inspection and surveillance functions, MoH will receive the support of the NIH, Invima, the National Superintendence of Health and the territorial health directorates.

For more information contact our team